Bristol Myers Squibb and Otsuka Pharmaceutical were among the limited partners for what LSP said is Europe's largest ever life sciences VC fund.

Netherlands-based life sciences investment firm LSP closed a $600m fund yesterday having raised capital from backers including pharmaceutical firms Bristol Myers Squibb and Otsuka Pharmaceutical. LSP 6, which the firm claims is the largest life sciences venture capital fund ever raised in Europe, also features unnamed insurance firms, pension funds, wealth managers, family offices and…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.